J. Safra Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.22M Buy
5,671
+361
+7% +$366K 0.28% 34
2025
Q4
$5.71M Buy
5,310
+2,599
+96% +$2.49M 0.3% 33
2025
Q3
$2.07M Buy
2,711
+766
+39% +$570K 0.13% 44
2025
Q2
$1.52M Buy
1,945
+621
+47% +$483K 0.11% 42
2025
Q1
$1.09M Sell
1,324
-40
-3% -$33.3K 0.09% 45
2024
Q4
$1.06M Buy
1,364
+505
+59% +$418K 0.09% 39
2024
Q3
$754K Buy
859
+161
+23% +$145K 0.07% 37
2024
Q2
$632K Buy
698
+381
+120% +$305K 0.06% 32
2024
Q1
$247K Sell
317
-284
-47% -$202K 0.03% 38
2023
Q4
$350K Sell
601
-80
-12% -$46.7K 0.05% 26
2023
Q3
$366K Hold
681
0.05% 25
2023
Q2
$319K Hold
681
0.04% 27
2023
Q1
$234K Buy
+681
New +$230K 0.04% 35
2022
Q4
Sell
-97
Closed 105
2022
Q3
$0 Hold
97
﹤0.01% 70
2022
Q2
$0 Buy
97
+11
+13% +$3.3K ﹤0.01% 90
2022
Q1
$0 Buy
+86
New +$22.1K ﹤0.01% 94
2016
Q4
Sell
-211
Closed -$17K 86
2016
Q3
$17K Hold
211
0.03% 144
2016
Q2
$17K Buy
+211
New +$15.9K 0.03% 217

Other funds holding LLY

J. Safra Asset Management's LLY Position: Q1 2026 in Review

J. Safra Asset Management increased its Eli Lilly (LLY) stake by 6.8% in Q1 2026, buying an estimated $366K and bringing the position to 5,671 shares worth $5.22M. The position accounts for 0.28% of the portfolio, ranked #34.

J. Safra Asset Management first reported a position in LLY in Q2 2016 and has held it in 18 quarters since. The position peaked at $5.71M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • J. Safra Asset Management held 5,671 shares of Eli Lilly worth $5.22M as of Q1 2026.
  • J. Safra Asset Management bought 361 Eli Lilly shares in Q1 2026, an estimated $366K.
  • Eli Lilly made up 0.28% of J. Safra Asset Management's portfolio in Q1 2026, its #34 holding.
  • J. Safra Asset Management first reported a position in Eli Lilly in Q2 2016 and has held it in 18 quarters since.
  • J. Safra Asset Management's Eli Lilly position peaked at $5.71M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.